Manuela Ferracin

Professor of Pathology

University of Bologna

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Cancer Biology Cancer Biology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Manuela Ferracin is a Professor of Pathology at the University of Bologna, Italy. Her research focuses on molecular mechanisms in cancer, particularly in areas such as melanoma, Merkel cell carcinoma, and muscular dystrophies. She has published extensively on the roles of microRNAs and other biomarkers in cancer prognosis and therapy, as well as innovative techniques for virus detection. Her recent works include studies on CRISPR technology, vaccine-based immunotherapy, and the mutational landscape of various cancers.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (25)

Davide Campana

University of Bologna

ITALY

Manuela Ferracin

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Profibrotic Molecules Are Reduced in CRISPR-Edited Emery–Dreifuss Muscular Dystrophy Fibroblasts

Merkel Cell Carcinoma: An Updated Review Focused on Bone and Bone Marrow Metastases

Predictive Factors for Sentinel Lymph Node Positivity in Melanoma Patients—The Role of Liquid Biopsy, MicroRNA and Gene Expression Profile Panels

Vaccine-Based Immunotherapy for Oropharyngeal and Nasopharyngeal Cancers

Surfaces environmental monitoring of SARS-CoV-2: Loop mediated isothermal amplification (LAMP) and droplet digital PCR (ddPCR) in comparison with standard Reverse-Transcription quantitative polymerase chain reaction (RT-qPCR) techniques

Exploring the Common Mutational Landscape in Cutaneous Melanoma and Pancreatic Cancer

The 2024 Nobel Prize in Physiology or Medicine: microRNA Takes Center Stage

Circulating microRNAs and isomiRs as biomarkers for the initial insult and epileptogenesis in four experimental epilepsy models: The EPITARGET study

Targeting Isocitrate Dehydrogenase (IDH) in Solid Tumors: Current Evidence and Future Perspectives

Association of miR-146a-5p and miR-21-5p with Prognostic Features in Melanomas

A Systematic Review of Diagnostic and Prognostic Biomarkers for Head and Neck Cancer of Unknown Primary: An Unmet Clinical Need

Disclosing quantitative RT‐PCR raw data during manuscript submission: a call for action

Diagnostic and Prognostic Value of microRNAs in Patients with Laryngeal Cancer: A Systematic Review

Gene Expression Landscape of Chronic Myeloid Leukemia K562 Cells Overexpressing the Tumor Suppressor Gene PTPRG

microRNAs and Inflammatory Immune Response in SARS-CoV-2 Infection: A Narrative Review

MicroRNA and Metabolic Profiling of a Primary Ovarian Neuroendocrine Carcinoma Pulmonary-Type Reveals a High Degree of Similarity with Small Cell Lung Cancer

Circulating microRNA biomarkers in melanoma and non-melanoma skin cancer

Circulating miR-184 is a potential predictive biomarker of cardiac damage in Anderson–Fabry disease

P2X7 promotes metastatic spreading and triggers release of miRNA-containing exosomes and microvesicles from melanoma cells

Non-coding RNA dysregulation in skin cancers

Collaborators (25)

Davide Campana

Alessandro Mosca

Aiming Yu

Rosario Cultrera

Paola Lecca

Giulia Girolimetti

Elena Adinolfi

Simone Anfossi

Claudio Sorio

RICCARDO CASADEI

Bruno Carpentieri

Xiao-bo Zhong

Giuseppe Gasparre

Eric C. Schirmer

Ignacio Javier Fernandez

Antonio De Leo

ANNA MARIA GHELLI

Elisabetta Magnaterra

Massimo NEGRINI

Michael Ladomery

Gaetano Vattemi

Nicholas Delihas

Daniela Benati

Marcello Govoni

Rui Manuel Reis

Make your next move.